Corneal Collagen Cross-linking for Progressive Keratoconus

Completed · Phase 3

Conditions studied: Progressive Keratoconus

In brief

Prospective, randomized multicenter study to determine the safety and effectiveness of performing cornea collagen cross-linking (CXL) using riboflavin and UVA light in eyes with progressive keratoconus.

Key facts

Study ID

NCT00647699

Run by

Glaukos Corporation

People needed

147

Starts

2007-12-01

Expected to finish

2011-04-01

Last updated by the study team

2021-04-26

Who can join

Age: 14 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of keratoconus
• Documented progression over previous 24 months
• Decreased BSCVA
• Must complete all study visits

You may not qualify if…

• Prior corneal surgery or Intacs
• History of delayed wound healing

Where it is running

• Shiley Eye Center — La Jolla, California, United States
• Gordon -Weiss Vision Institute — San Diego, California, United States
• Center for Excellence in Eye Care — Miami, Florida, United States
• Price Vision Group — Indianapolis, Indiana, United States
• Durrie Vision — Kansas City, Kansas, United States
• Wilmer Eye Institute at Johns Hopkins University — Baltimore, Maryland, United States
• Minnesota Eye Consultants — Minneapolis, Minnesota, United States
• Cornea & Laser Eye Institute; Hersh Vision Group — Teaneck, New Jersey, United States
• Edward Harkness Eye Institute at Columbia University Medical Center — New York, New York, United States
• Ophthalmic Consultants of Long Island — Rockville Centre, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.